3532 articles – 5253 Notices  [english version]

inserm-00418798, version 1

Identification of threonine 348 as a residue involved in aminopeptidase A substrate specificity.

Cédric Claperon 1, Inmaculada Banegas-Font 1, Xavier Iturrioz 1, Raphael Rozenfeld 1, Bernard Maigret 2, Catherine Llorens-Cortes 1

The Journal of Biological Chemistry 284, 16 (2009) 10618-26

  • 1 :  Neuropeptides centraux et régulations hydrique et cardiovasculaire

  • INSERM : U691 – Collège de France – Université Pierre et Marie Curie [UPMC] - Paris VI 11, Place Marcelin Berthelot 75231 Paris Cedex 05 France
  • 2 :  ORPAILLEUR (INRIA Lorraine - LORIA)

  • INRIA – CNRS : UMR7503 – Université Henri Poincaré - Nancy I – Université Nancy II – Institut National Polytechnique de Lorraine (INPL) France

Références bibliographiques

  • Type de publication : Articles dans des revues avec comité de lecture
  • PMID: identifiant
    de la référence Pubmed :
    (19228697)
  • titre : Identification of threonine 348 as a residue involved in aminopeptidase A substrate specificity.
  • résumé : Aminopeptidase A (APA; EC 3.4.11.7) is a membrane-bound zinc metalloprotease cleaving in the brain the N-terminal aspartyl residue of angiotensin II to generate angiotensin III, which exerts a tonic stimulatory effect on the central control of blood pressure in hypertensive animals. We docked the specific APA inhibitor, glutamate phosphonate, in the three-dimensional model of the mouse APA ectodomain in the presence of Ca(2+). In the S1 subsite of this model, the Ca(2+) atom was coordinated with Asp-213, Asp-218,y and Glu-215 and three water molecules, one of which formed a hydrogen bond with the carboxylate side chain of the inhibitor. We report here that the carboxylate side chain of glutamate phosphonate also formed a hydrogen bond with the alcohol side chain of Thr-348. Mutagenic replacement of Thr-348 with an aspartate, tyrosine, or serine residue led to a modification of the hydrolysis velocity, with no change in the affinity of the recombinant enzymes for the substrate GluNA, either in the absence or presence of Ca(2+). In the absence of Ca(2+), the mutations modified the substrate specificity of APA, which was nevertheless restored by the addition of Ca(2+). An analysis of three-dimensional models of the corresponding Thr-348 mutants revealed that the interaction between this residue and the inhibitor was abolished or disturbed, leading to a change in the position of the inhibitor in the active site. These findings demonstrate a key role of Thr-348 in substrate specificity of APA for N-terminal acidic amino acids by insuring the optimal positioning of the substrate during catalysis.
  • domaine : Sciences du Vivant/Médecine humaine et pathologie/Endocrinologie et métabolisme
  • langue du texte
    intégral :
    Anglais
  • ISSN : 0021-9258
  • DOI : 10.1074/jbc.M806783200
  • journal : The Journal of Biological Chemistry
  • Audience : internationale
  • date de publication : 17/04/2009
  • date de publication
    électronique :
    19/02/2009
  • volume : 284
  • numéro : 16
  • page, identifiant, ... : 10618-26
  • Descripteur(s) MeSH : Adenosine – Animals – Arvicolinae – Blotting – Western – CHO Cells – Calcium – Cell Line – Cricetinae – Humans – Kidney – Microscopy – Confocal – Protein Binding – RNA Interference – RNA – Small Interfering – Radioligand Assay – Receptor – Adenosine A2B – Adenosine A3 – Receptors – G-Protein-Coupled – Ghrelin – Transfection – Angiotensin III – Glutamates – Glutamyl Aminopeptidase – Mice – Molecular Conformation – Molecular Structure – Mutagenesis – Site-Directed – Phosphonic Acids – Recombinant Proteins – Substrate Specificity – Threonine
 
  • inserm-00418798, version 1
  • oai:www.hal.inserm.fr:inserm-00418798
  • Contributeur : 
  • Soumis le : Lundi 21 Septembre 2009, 16:20:45
  • Dernière modification le : Jeudi 8 Octobre 2009, 10:18:48